Logo
x

Search

Subscribe Now

All Posts by Date

Pfenex Reports Results of Human Factors Study for its PF708 Candidate (biosimilar- teriparatide)

Pfenex Reports Results of Human Factors Study for its PF708 Candidate (biosimilar- teriparatide)

  • October 14, 2019
PharmaShots Weekly Snapshot (October 07-11, 2019)

PharmaShots Weekly Snapshot (October 07-11, 2019)

  • October 14, 2019
ImaginAb Collaborates with Three Global Pharmaceutical Companies Focusing on the Development of its CD8 ImmunoPET Technology

ImaginAb Collaborates with Three Global Pharmaceutical Companies Focusing on the Development of its CD8 ImmunoPET Technology

  • October 14, 2019
Roche Reports Results of MabThera/Rituxan (rituximab) in P-III PEMPHIX Study for Pemphigus Vulgaris

Roche Reports Results of MabThera/Rituxan (rituximab) in P-III PEMPHIX Study for Pemphigus Vulgaris

  • October 14, 2019
Lilly's Reyvow (lasmiditan) Receives FDA's Approval as the First Therapy in a New Class of Acute Treatment for Migraine

Lilly's Reyvow (lasmiditan) Receives FDA's Approval as the First Therapy in a New Class of Acute Treatment for Migraine

  • October 14, 2019
Exact Sciences and Mayo Clinic Initiate Voyage Study Evaluating the Real-World Impact of Cologuard

Exact Sciences and Mayo Clinic Initiate Voyage Study Evaluating the Real-World Impact of Cologuard

  • October 14, 2019
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.